Deok‐Hwan Yang

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 386 citations · Full text

Medicine, Clinical Sciences, Oncology +15

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma

D. H. Kim, Hyunuk Jung, J. G. Kim et al. · Blood · 2006 · 193 citations · Full text

Life Sciences, Hematology, Oncology +5

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim et al. · Blood · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacology +11

Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study

Seok Jin Kim, Deok‐Hwan Yang, Jin Seok Kim et al. · Annals of Hematology · 2014 · 126 citations · Full text

Medicine, Oncology, Otolaryngology +14

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma

Ho‐Young Yhim, Jin Seok Kim, Yeung‐Chul Mun et al. · Biology of Blood and Marrow Transplantation · 2015 · 88 citations · Full text

Medicine, Oncology, Immunotherapy +12